Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVC-422 in Impetigo
NCT01367314Phase 2Completed
- Sponsor
- NovaBay Pharmaceuticals, Inc.
- Start
- Aug 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of auriclosene in impetigo, sponsored by NovaBay Pharmaceuticals, Inc.. Started Aug 2009; status: completed.
02
Drugs
auriclosene
03
Conditions
impetigo
Beyond the preview
Go deeper on NCT01367314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01367314.